DNANudge: Coronavirus

(asked on 8th September 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he made of the (a) financial viability and (b) resilience of DNA Nudge prior to the award of a Government contract with a value of £161 million.


Answered by
Helen Whately Portrait
Helen Whately
Minister of State (Department of Health and Social Care)
This question was answered on 23rd September 2020

Financial due diligence of DNA Nudge was conducted during the procurement process before awarding a contract. Financial and commercial analysis was undertaken of the business model before it was assessed that the organisation was able to deliver.

The product went through a clinical validation process that confirmed DNA Nudge test met the quality standard required and the product has obtained approval from the Medicines and Healthcare products Regulatory Agency.

DNA Nudge's resilience and ability to deliver has also been tested through an initial pilot successfully delivered. A pilot was first conducted with an order of 40 machines deployed to seven London hospitals initially which was delivered successfully.

Reticulating Splines